Effects of IL-12 on immune responses induced by transcutaneous immunization with antigens formulated in a novel lipid-based biphasic delivery system

Vaccine

Volumn 18, Issue 17, 2000, Pages 1847-1854

  Baca Estrada, Maria E ^a   Foldvari, Marianna ^b   Ewen, Catherine ^a   Badea, Ildiko ^b   Babiuk, Lorne A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Cytokines; Th1 Th2; Transcutaneous immunization

Indexed keywords

INTERLEUKIN 12; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; MANNHEIMIA HAEMOLYTICA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EPITOPES; EXOTOXINS; FEMALE; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LIPIDS; LYMPH NODES; MICE; MICE, INBRED BALB C; MURAMIDASE; SPLEEN;

EID: 0034003998     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00379-5     Document Type: Article

References (40)

1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
2. Silberberg-Sinakin I., Thorbecke G.I., Baer R.L., Berezowsky V. Antigen-bearing Langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell. Immunol. 25:1976;137-141.
3. Hoesfmit E.C.M., Duijvestijn A.M., Kamperdijk E.W.A. Relation between Langerhans cells, vailed cells and iterdigitating cells. Immunobiol. 161:1982;225-265.
4. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunization by parental, mucosal and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 90:1993;11478-11482.
5. Leitner W.W., Seguin M.C., Ballou W.R., Seitz J.P., Schultz A.M., Sheehy M.J., Lyon J.A. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J. Immunol. 159:1997;6112-6119.
6. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., Falo L.D. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1996;1122-1128.
7. Glenn G.M., Rao M., Matyas G.R., Alving C.R. Skin immunization made possible by cholera toxin. Nature. 391:1998;851.
8. Glenn G.M., Scharton-Kersten T., Vassell R., Mallett C.P., Hale L.T., Alving C.R. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J. Immunol. 161:1998;3211-3214.
9. Paul A., Cevc G., Bachhawat B.K. Transdermal immunization with large proteins by means of ultradeformable drug carriers. Eur. J. Immunol. 25:1995;3521-3524.
10. Afonso L.C.C., Scharton T.M., Vieira L.Q., Wysocka M., Trinchieri G., Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science. 263:1994;235-237.
11. Manetti R., Parronchi P., Giudizi M.G., Piccinni M.P., Maggi E., Trinchieri G., Romagnani S. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1993;1199-1204.
12. Sypek J.P., Chung C.L., Mayor S.E., Subramanyam J.M., Goldman S.J., Sieburth D.S., Wolf S.F., Schaub R.G. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1993;1797-1802.
13. Heinzel F.P., Schoenhaut D.S., Rerko R.M., Rosser L.E., Gately M.K. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1993;1505-1509.
14. Flynn J.L., Goldstein M.M., Triebold K.J., Sypek J., Wolf S., Bloom B.R. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:1995;2515-2524.
15. Sur S., Lam J., Bouchard P., Sigounas A., Holbert D., Metzger W.J. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J. Immunol. 157:1996;4173-4180.
16. Hogan S.P., Foster P.S., Tan X., Ramsay A.J. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity. Eur. J. Immunol. 28:1998;413-423.
17. Schwarze J., Hamelmann E., Cieslewicz G., Tomkinson A., Joetham A., Bradley K., Gelfand E.W. Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice. J. Allerg. Clin. Immunol. 102:1998;86-93.
18. Tahara H., Zeh H.J. 3rd, Storkus W.J., Pappo I., Watkins S.C., Gubler U., Wolf S.F., Robbins P.D., Lotze M.T. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res. 54:1994;182-189.
19. Brunda M.J., Luistro L., Warrier R.R., Wright R.B., Hubbard B.R., Murphy M., Wolf S.F., Gately M.K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1993;1223-1230.
20. Wynn T.A., Jankovic D., Hieny S., Cheever A.W., Sher A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression IgE production, and tissue eosinophilia. J. Immunol. 154:1995;4701-4709.
21. Bliss J., Van Cleve V., Murray K., Weincis A., Ketchum M., Maylor R., Haire T., Resmini C., Abbas A.K., Wolf S.F. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J. Immunol. 156:1996;887-894.
22. Baca-Estrada M.E., Foldvari M., Snider M., van Drunen Littel-van den Hurk S., Babiuk L.A. Effect of IL-4 and IL-12 on the induction of immune response to bovine herpesvirus type-1 glycoprotein D. Vaccine. 15:1997;1753-1760.
23. Foldvari M., Moreland M. Clinical observations with topical liposome encapsultaed interferon alpha for the treatment of genital papillomavirus infections. J. Liposome. Res. 7:1997;115-126.
24. Foldvari M. 1998. Biphasic lipid vesicles. US Patent No. 5,853,755.
25. Hardland R.J., Potter A.A., van Drunen Littel-van den Hurk S., van Donkersgoed J., Parker M.P., Zamb T.J., Janzen E.D. The effect of subunit midified live bovine herpesvirus-1 vaccines on the efficacy of a recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease in feedlot calves. Can. Vet. J. 33:1992;734-741.
26. McKnight A.J., Zimmer G.J., Fogelman I., Wolf S.F., Abbas A.K. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:1994;2172-2179.
27. Wang L.F., Lin J.Y., Hsieh K.H., Lin R.H. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. J. Immunol. 156:1996;4079-4082.
28. Tang D., Shi Z., Curiel D.T. Vaccination onto bare skin. Nature. 388:1997;729-730.
29. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278-2284.
30. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine response elicited by DNA vaccination are dependent on the route of vactor DNA delivery. J. Virol. 70:1996;6119-6125.
31. Kondo H., Ichikawa Y., Imokawa G. Percutaneous sensitization with allergens through barreir-disrupted skin elicits a Th2-dominant cytokine response. Eur. J. Immunol. 28:1998;769-779.
32. Germann T., Bongratz M., Dlugonska H., Hess H., Schmitt E., Kolbe L., Kolsch E., Podlaski F.J., Gately M.K., Rude E. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibodies subclasses in vivo. Eur. J. Immunol. 25:1995;823-829.
33. Marinaro M., Boyaka P.N., Finkelman F.D., Kiyono H., Jackson R.J., Jirillo E., McGhee J. Oral but not parental interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J. Exp. Med. 185:1997;415-427.
34. Morris S.C., Madden K.B., Adamovicz J.J., Gause B.R., Gately M.K., Finkelman F.D. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1994;1047-1056.
35. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., Boyer J.D., Weiner D.B. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:1997;816-826.
36. Buchanan J.M., Vogel L.A., Van Cleave V.H., Metzger D.W. Interleukin 12 alters the isotype-restricted antibody response of mice to hen eggwhite lysozyme. Int. Immunol. 7:1995;1519-1528.
37. Yang Y., Trinchieri G., Wilson J.M. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1:1995;890-893.
38. Grohmann U., Belladonna M.L., Bianchi R., Orabona C., Ayroldi E., Fioretti M.C., Puccetti P. IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production. Immunity. 9:1998;315-323.
39. Suemoto Y., Ando O., Kurimoto M., Horikawa T., Ichihashi M. IL-12 promotes the accessory cell function of epidermal Langerhans cells. J. Dermatol. Sci. 18:1998;98-108.
40. Barouch D.H., Santra S., Steenbeke T.D., Zheng X.X., Perry H.C., Davies M.-E., Freed D.C., Craiu A., Strom T.B., Shiver J.W., Letvin N.L. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J. Immunol. 161:1998;1875-1882.